Type of Publication: | Contribution to a collection |
Publication status: | Published |
Author: | Basler, Michael; Groettrup, Marcus |
Year of publication: | 2019 |
Published in: | Antigen Processing : Methods and Protocols / Endert, Peter van (ed.). - second edition. - New York, NY : Humana Press, 2019. - (Methods in Molecular Biology ; 1988). - pp. 59-69. - ISBN 978-1-4939-9449-6 |
DOI (citable link): | https://dx.doi.org/10.1007/978-1-4939-9450-2_5 |
Summary: |
The major histocompatibility complex (MHC) class I restricted pathway of antigen processing allows the presentation of intracellular antigens to cytotoxic T lymphocytes. The proteasome is the main protease in the cytoplasm and the nucleus, which is responsible for the generation of most peptide ligands of MHC-I molecules. Peptides produced by the proteasome can be further trimmed or destroyed by numerous cytosolic or endoplasmic reticulum (ER) luminal proteases. Small molecule inhibitors are useful tools for probing the role of proteases in MHC class I antigen processing. Here, we describe different methods to test the impact of protease inhibitors in antigen presentation assays.
|
Subject (DDC): | 570 Biosciences, Biology |
Bibliography of Konstanz: | Yes |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
BASLER, Michael, Marcus GROETTRUP, 2019. Testing the Impact of Protease Inhibitors in Antigen Presentation Assays. In: ENDERT, Peter van, ed.. Antigen Processing : Methods and Protocols. second edition. New York, NY:Humana Press, pp. 59-69. ISBN 978-1-4939-9449-6. Available under: doi: 10.1007/978-1-4939-9450-2_5
@incollection{Basler2019Testi-45967, title={Testing the Impact of Protease Inhibitors in Antigen Presentation Assays}, year={2019}, doi={10.1007/978-1-4939-9450-2_5}, edition={second edition}, number={1988}, isbn={978-1-4939-9449-6}, address={New York, NY}, publisher={Humana Press}, series={Methods in Molecular Biology}, booktitle={Antigen Processing : Methods and Protocols}, pages={59--69}, editor={Endert, Peter van}, author={Basler, Michael and Groettrup, Marcus} }
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/45967"> <dcterms:issued>2019</dcterms:issued> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:creator>Groettrup, Marcus</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-11T09:33:36Z</dc:date> <dc:language>eng</dc:language> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2019-06-11T09:33:36Z</dcterms:available> <dcterms:abstract xml:lang="eng">The major histocompatibility complex (MHC) class I restricted pathway of antigen processing allows the presentation of intracellular antigens to cytotoxic T lymphocytes. The proteasome is the main protease in the cytoplasm and the nucleus, which is responsible for the generation of most peptide ligands of MHC-I molecules. Peptides produced by the proteasome can be further trimmed or destroyed by numerous cytosolic or endoplasmic reticulum (ER) luminal proteases. Small molecule inhibitors are useful tools for probing the role of proteases in MHC class I antigen processing. Here, we describe different methods to test the impact of protease inhibitors in antigen presentation assays.</dcterms:abstract> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Basler, Michael</dc:creator> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/45967"/> <dc:contributor>Groettrup, Marcus</dc:contributor> <dcterms:title>Testing the Impact of Protease Inhibitors in Antigen Presentation Assays</dcterms:title> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:contributor>Basler, Michael</dc:contributor> </rdf:Description> </rdf:RDF>